INS and metabolic dysfunction-associated steatohepatitis: In animal models of NASH and T2D it attenuates several features of liver pathology, reverses hyperglycemia, and enhances insulin sensitivity; in addition, in vitro effects to suppress DNL (hepatocytes), attenuate inflammation (macrophages), or to potentially reduce fibrosis (stellate cells) have been observed in human cell-based assays.23